Your browser doesn't support javascript.
loading
Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age.
Kriemler, Lilian; Rudin, Salome; Gawinecka, Joanna; Gross, Felix; Arnold, Markus; Schweizer, Juliane; Westphal, Laura; Inauen, Corinne; Pokorny, Thomas; Dittrich, Tolga; Toebak, Anna; Arnold, Marcel; Christ-Crain, Mirjam; von Eckardstein, Arnold; Rentsch, Katharina; Katan, Mira; De Marchis, Gian Marco.
Affiliation
  • Kriemler L; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Rudin S; Department of Clinical Research, University of Basel, Basel, Switzerland.
  • Gawinecka J; Clinic for Internal Medicine, Kantonsspital Schaffhausen, Schaffhausen, Switzerland.
  • Gross F; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Arnold M; Department of Clinical Research, University of Basel, Basel, Switzerland.
  • Schweizer J; Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Switzerland.
  • Westphal L; Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Inauen C; Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Pokorny T; Department of Neurology, Stadtspital Zürich, Triemli, Zurich, Switzerland.
  • Dittrich T; Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Toebak A; Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Arnold M; Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Christ-Crain M; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland.
  • von Eckardstein A; Department of Clinical Research, University of Basel, Basel, Switzerland.
  • Rentsch K; Department of Neurology and Stroke Center, Kantonsspital St. Gallen, St.Gallen, Switzerland.
  • Katan M; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland.
  • De Marchis GM; Department of Clinical Research, University of Basel, Basel, Switzerland.
Eur Stroke J ; 9(2): 494-500, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38279527
ABSTRACT
BACKGROUND AND

AIMS:

Low density lipoprotein (LDL-C) and other atherogenic lipoproteins are coated by apolipoprotein B100 (apoB). The correlation between LDL-C and apoB is usually thight, but in some cases LDL-C underestimates apoB levels and residual cardiovascular risk. We aimed to assess if a discordance of LDL-C-levels with apoB levels is associated with LAA stroke.

METHODS:

We included patients with an acute ischemic stroke from two prospective studies enrolled at the University Hospital Bern, Basel and Zurich, Switzerland. LDL-C and apoB were measured within 24 h of symptom onset. By linear regression, for each LDL-C, we computed the expected apoB level assuming a perfect correlation. Higher-than-expected apoB was defined as apoB level being in the upper residual tertile.

RESULTS:

Overall, we included 1783 patients, of which 260 had a LAA stroke (15%). In the overall cohort, higher-than-expected apoB values were not associated with LAA. However, a significant interaction with age was present. Among the 738 patients ⩽70 years of age, a higher-than-expected apoB was more frequent in patients with LAA- versus non LAA-stroke (48% vs 36%, p = 0.02). In multivariate analysis, a higher-than-expected apoB was associated with LAA stroke (aOR = aOR 2.48, 95%CI 1.14-5.38). Among those aged ⩽70 years and with LAA, 11.7% had higher than guideline-recommended apoB despite LDL-C ⩽ 1.8 mmol/L (<70 mg/dl), compared to 5.9% among patients with other stroke etiologies (p = 0.04). A triglyceride cut-off of ⩾0.95 mmol/L had, in external validation, a sensitivity of 71% and specificity of 52% for apoB ⩾ 0.65 g/L among patients with LDL-C <1.8 mmol/L.

CONCLUSIONS:

Among patients aged ⩽70 years, a higher-than-expected apoB was independently associated with LAA stroke. Measuring apoB may help identify younger stroke patients potentially benefiting from intensified lipid-lowering therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins B / Atherosclerosis / Ischemic Stroke / Cholesterol, LDL Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Stroke J Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins B / Atherosclerosis / Ischemic Stroke / Cholesterol, LDL Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Stroke J Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Reino Unido